Delia
D'Avola
Consultora Médica
Publicaciones en las que colabora con Delia D'Avola (40)
2023
-
Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 869-879
2022
-
Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood
Bioengineering and Translational Medicine, Vol. 7, Núm. 3
2019
-
Hepatocellular Carcinoma: Essentials Interventional Radiologists Need to Know
CardioVascular and Interventional Radiology, Vol. 42, Núm. 9, pp. 1262-1270
2017
-
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil
Liver Transplantation, Vol. 23, Núm. 4, pp. 498-509
-
Conversion from calcineurin Inhibitor-Based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation
Annals of Transplantation, Vol. 22, pp. 141-147
-
Immune checkpoint inhibitors for the treatment of hepatocellular carcinoma
Immunotherapy of Hepatocellular Carcinoma (Springer International Publishing), pp. 51-68
-
Modulating Immune Responses to Overcome Resistance in Hepatocellular Carcinoma
RESISTANCE TO MOLECULAR THERAPIES FOR HEPATOCELLULAR CARCINOMA (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 25-43
-
NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma
Oncotarget, Vol. 8, Núm. 25, pp. 40967-40981
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
2016
-
Controlling Diabetes after Liver Transplantation: Room for Improvement
Transplantation, Vol. 100, Núm. 10, pp. e66-e73
-
Factors related to increased resting energy expenditure in men with liver cirrhosis
European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 2, pp. 139-145
-
Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783
-
Recombinant AAV Integration Is Not Associated with Hepatic Genotoxicity in Nonhuman Primates and Patients
Molecular Therapy, Vol. 24, Núm. 6, pp. 1100-1105
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
-
Immune monitoring of immunosuppression withdrawal of liver transplant recipients
Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116
-
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
Liver International, Vol. 35, Núm. 6, pp. 1715-1721
-
Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation
Liver International, Vol. 35, Núm. 5, pp. 1590-1596
-
V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante
Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637
2014
-
Comparación de las sondas M y XL para estimar la rigidez hepática por medio de elastografía de transición
Gastroenterologia y Hepatologia, Vol. 37, Núm. 4, pp. 233-239
-
Is liver biopsy necessary in the evaluation of a living donor for liver transplantation?
Transplantation Proceedings